Aspergillus infection study for hematology patients
Part of Infections clinical trials.
This study looks at Aspergillus infections in people admitted to the hematology ward. It aims to understand how common these infections are and how they affect patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must sign a consent form agreeing to participate.
- You must be admitted to the hematology ward at San Matteo Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is developing a tool to better predict fungal pneumonia in people who come to the emergency department or hospital with pneumonia. By analyzing samples from your lungs and other data, researchers hope to improve diagnosis and treatment decisions.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study looks at how chronic pulmonary aspergillosis (a long-term lung infection) affects your daily life, health, and overall well-being. By joining, you'll help researchers understand what it's like to live with this condition.
This study looks closely at how influenza (the flu) and a specific kind of lung fungus called Aspergillus affect people who are sick in the ICU with breathing problems. It may help doctors better understand the cause and improve treatment for severe lung infections.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
This study looks for parasitic infections in people with different blood disorders, including anemia and blood cancers. It aims to understand if parasites are more common in these patients.
Hear when a new Aspergillus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.